THE HEPATOPROTECTOR ROPREN FOR THE TREATMENT OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: A PROSPECTIVE OBSERVATIONAL STUDY.

E V GolovanovaN A ShaposhnikovaE S MelkinaV S Soultanov

Published in: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (2018)

Ropren® treatment increased the elasticity of the liver and might be useful to reduce the risk of cirrhosis. Although the sample size in this study was small, the results demonstrated that a randomised-controlled trial of Ropren? for NASH is warranted.

Keyphrases

combination therapy
replacement therapy
smoking cessation